ArticleTherapeutic advances in medical oncology2026
Dalpiciclib combined with endocrine therapy for patients with HR+/HER2- metastatic breast cancer: a multicenter real-world study.
Xuelian Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.